Trinity Bivalacqua, MD, PhD, addresses updates in high-risk BCG-unresponsive NMIBC treatment presented at ASCO 2024.
UroView
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
2
FDA updates in urology: September 2026
3
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
4
SBRT, prostatectomy show comparable long-term disease control in PACE-A trial
5